# FDA Recalls Xanax XR Batch Over Potency Questions
The FDA has recalled a batch of Xanax XR (extended-release alprazolam) due to concerns that the medication may not deliver its intended dose effectively. The recall affects specific lots of the anxiety medication manufactured by Pfizer, the drug's maker.
Xanax XR releases medication gradually throughout the day, making it a preferred treatment option for patients with generalized anxiety disorder and panic disorder who need steady symptom management. When the extended-release mechanism fails, patients may experience inconsistent drug levels in their bloodstream, leading to breakthrough anxiety symptoms or, conversely, unexpected side effects.
The FDA initiated the recall after manufacturing quality control issues were identified during routine testing. Patients taking affected batches may not receive the full therapeutic benefit they expect from their prescribed dose. This creates a real clinical problem: someone stabilized on their current regimen might suddenly find their anxiety symptoms return without warning.
Pfizer has issued detailed guidance about which lot numbers are included in the recall. Patients currently taking Xanax XR should check their medication bottle for the lot number and compare it against the recall list posted on both the FDA and Pfizer websites. Those with affected batches should contact their pharmacist or prescriber immediately.
Stopping alprazolam abruptly carries risks, including rebound anxiety and withdrawal symptoms. Patients should not discontinue their medication without medical guidance. Instead, they should work with their healthcare provider to obtain unaffected batches or explore alternative formulations like immediate-release alprazolam while waiting for new stock.
This recall underscores the importance of pharmaceutical manufacturing standards. Extended-release formulations depend on precise engineering of the tablet's dissolution mechanism. Any deviation from specifications means patients receive substandard treatment without realizing it. Anyone affected should reach out to their pharmacist prompt